These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3911480)

  • 1. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
    Basista M; Grodzińska L; Swies J
    Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
    Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
    J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antithrombotic properties of the active metabolite of molsidomine, SIN-1].
    Grodzinska L; Basista M; Koenig E
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):233-4. PubMed ID: 3550644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of aspirin, molsidomine, trapidil, and some trapidil derivatives on arachidonic acid induced reversible thrombocyte aggregation in the rabbit.
    Zehl U; Mest HJ; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S381-4. PubMed ID: 6440554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease.
    Bieroń K; Grodzińska L; Kostka-Trabka E; Gryglewski RJ
    Wien Klin Wochenschr; 1993; 105(1):7-11. PubMed ID: 8438599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrendipine-stimulated release of prostacyclin-like substance in normal and atherosclerotic animals.
    Grodzińska L; Basista M; Basista E; Sławiński M; Swies J; Stachura J; Ohlrogge R
    Arzneimittelforschung; 1987 Apr; 37(4):412-5. PubMed ID: 3300663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of molsidomine, an anti-anginal drug, on arachidonic acid metabolism in human platelets.
    Croset M; Lagarde M
    Biomed Biochim Acta; 1984; 43(8-9):S354-7. PubMed ID: 6440549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular mechanism of action of molsidomine. Bioinduction of prostacyclin].
    Poincelot B; Russo-Marie F
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):535-7. PubMed ID: 6421223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.
    Nishikawa M; Kanamori M; Hidaka H
    J Pharmacol Exp Ther; 1982 Jan; 220(1):183-90. PubMed ID: 6118429
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of aspirin on the hemodynamic effects of molsidomine in healthy volunteers].
    Weber S; de Lauture D; Puechavy C; Pipeau C; Chazelle F; Degeorges M
    Therapie; 1986; 41(3):153-7. PubMed ID: 3529482
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
    Silberbauer K; Slany J; Sinzinger H; Punzengruber C
    Z Kardiol; 1982 Aug; 71(8):539-43. PubMed ID: 6753382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
    Bult H; Fret HR; Herman AG
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
    Hart S; Deniz A; Sommer B; Kietzmann M; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 Dec; 102(12):476-80. PubMed ID: 8591748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
    Berdeaux A; Giudicelli JF
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of SIN 1 on the interactions of endothelial cells and thrombocytes].
    Kirchmaier CM; Altorjay I; Bellinger O; Breddin HK
    Z Kardiol; 1991; 80 Suppl 5():13-6. PubMed ID: 1776329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions.
    Jung F; Mrowietz C; Seyfert UT; Grewe R; Franke RP
    Clin Hemorheol Microcirc; 2003; 28(4):189-99. PubMed ID: 12897410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of five Thai snake venoms on coagulation, fibrinolysis and platelet aggregation.
    Mitrakul C
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):266-75. PubMed ID: 524153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.